title: Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany - Implications for Price Discounts.
authors.affiliation: Herescon GmbH, Hannover, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Theidel
authors.affiliation: Herescon GmbH, Hannover, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Wahlers
authors.affiliation: Herescon GmbH, Hannover, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Mittendorf